Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-26T05:55:26.613Z Has data issue: false hasContentIssue false

‘Pseudo-paraplegia': a chronic psychotic sequela of organophosphate exposure in schizophrenia

Published online by Cambridge University Press:  24 June 2014

Ting-Gang Chang
Affiliation:
Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Taiwan Department of Psychiatry, Changhua Christian Hospital, Taiwan
Wen-Yu Hsu
Affiliation:
Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Taiwan Department of Psychiatry, Changhua Christian Hospital, Taiwan
Yen-Kuang Yang
Affiliation:
Department of Psychiatry, National Cheng Kung University and Hospital, Taiwan
Jui-Ting Liu*
Affiliation:
Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, Taiwan Department of Psychiatry, Changhua Christian Hospital, Taiwan
*
Jui-Ting Liu, MD Department of Psychiatry, Lu-Tung Branch of Changhua Christian Hospital, 888 Lu-Tung Road, Lu-Kang Town, Changhua County, Taiwan. Tel: +886 4 7789595 (ext. 1583); Fax: +886 4 7769780; E-mail: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Metcalf, DR, Holmes, JH Toxicology and physiology. EEG, psychological, and neurological alterations in humans with organophosphorus exposure. Ann N Y Acad Sci 1969;160:357365. CrossRefGoogle ScholarPubMed
2. Savage, EP, Keefe, TJ, Mounce, LM, Heaton, RK, Lewis, JA, Burcar, PJ. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health 1988;43:3845. CrossRefGoogle ScholarPubMed
3. Tan, DH, Peng, SQ, Wu, YL, Wang, YM, Lu, CF, Yan, CH. Chronic organophosphate (OP)-induced neuropsychiatric disorder is a withdrawal syndrome. Med Hypotheses 2009;72: 405406. CrossRefGoogle ScholarPubMed
4. Tandon, R, Greden, JF. Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/ dopaminergic interactions in schizophrenia. Arch Gen Psychiatry 1989;46:745753. CrossRefGoogle Scholar
5. Scarr, E, Dean, B. Role of the cholinergic system in the pathology and treatment of schizophrenia. Expert Rev Neurother 2009;9:7386. CrossRefGoogle ScholarPubMed
6. Ali, SF, Hasan, M, Tariq, M. Levels of dopamine, norepinephrine & 5-hydroxytryptamine in different regions of rat brain & spinal cord following chronic administration of organophosphate pesticide dichlorvos. Indian J Exp Biol 1979;17:424426. Google ScholarPubMed
7. Geyer, MA, Vollenweider, FX. Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 2008;29:445453. CrossRefGoogle ScholarPubMed
8. Slotkin, TA, Seidler, FJ. Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull 2007;72:232274. CrossRefGoogle ScholarPubMed
9. Scarr, E. Muscarinic receptors in psychiatric disorders – can we mimic ‘health'? Neurosignals 2009;17:298310. CrossRefGoogle ScholarPubMed
10. Bennouna, M, Greene, VB, Defranoux, L. Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link? Encephale 2007;33:616620. CrossRefGoogle ScholarPubMed